PharmAus is the annual showcase of global pharmaceutical innovation and its life-changing benefits for Australian patients.
Wednesday 3 September 2025 – Parliament House Canberra
With guest speakers and interactive exhibition stands sharing information about new treatments, research and clinical trials, PharmAus 2025 highlights the importance of the industry to patients and communities, and demonstrates how innovative medicines contribute to the health and economic prosperity of the nation.
The 2025 theme, The Best New Medicines When You Need Them, highlights the urgent need for reform to the Pharmaceutical Benefits Scheme so Australians have faster and more equitable access to medicines that have already been approved by the TGA as safe for use in Australia.
PharmAus 2025 will bring together more than 350 guests from Australia’s innovative pharmaceutical industry as well as patient advocacy groups, government, health peak bodies, research and academia for what promises to be a fantastic evening of engagement with parliamentarians, networking, and exhibitions.
Guest speakers
The Hon Mark Butler MP, Minister for Health and Aged Care, Minister for Disability and the National Disability insurance Scheme
Senator the Hon Anne Ruston, Shadow Minister for Health and Aged Care, Shadow Minister for Disability and the National Disability Insurance Scheme
TIME | PROGRAM |
4:30-5:35pm | PharmAus industry showcase networking, Vox pop filming and catering commences |
5:35pm | Welcome and Opening Remarks Introduction of Maria Rossotti, Breast cancer thriver & Founder of Breasties Hub by CEO of Medicines Australia, Ms Liz de Somer |
Address by Maria Rossotti, Breast cancer survivor & Founder of Breasties Hub | |
Patient Interviews Deidre Mackechnie, Executive Officer of the Australian Patient Advocacy Alliance interviews Dr Monique Ryan MP Maria Rossotti, Breast cancer survivor & Founder of Breasties Hub interviews Dr Gordon Reid MP | |
Opening Remarks and Introductions by Chair of Medicines Australia, Ms Sue MacLeman | |
Keynote Address by Minister for Health, the Hon Mark Butler MP | |
Address by Shadow Minister for Health, Senator the Hon Anne Ruston | |
6:55pm | Thank you and closing remarks by CEO of Medicines Australia, Ms Liz de Somer |
7:00pm | Industry showcase networking and Vox pop filming continues |
7:30pm | PharmAus 2025 concludes |
Exhibitors
AbbVie | Johnson & Johnson Innovative Medicine * |
Alexion Australia | Melanoma & Skin Cancer Advocacy Network |
Amgen * | Merck Healthcare |
Argenx * | Neurological Alliance Australia |
Astra Zeneca | Organon ANZ |
Biogen Australia Pty Ltd * | Pfizer Australia |
Bristol-Myers Squibb Australia * | Rare Voices Australia * |
Chiesi Australia * | Roche |
Eczema Support Australia | RxPx |
Eli Lilly | Sanofi * |
GSK Australia | |
* Collaborating with Patient Group(s) |
We are delighted to welcome Members and Patient Groups who will be exhibiting at PharmAus featuring a range of exciting showcases to demonstrate the latest innovations, ideas, and collaborations including:
– VR and simulation activities to experience living with Myasthenia Gravis/ Chronic Inflammatory Demyelinating Polyneuropathy (MG/CIDP)
– Alzheimer’s Decision Game designed to engage audiences on Alzheimer’s related policy and budgeting scenarios
– A VISIA system showing UV damages and determines “true skin age”
– Hands-on demonstration of the JADA system in controlling postpartum haemorrhage
– Point-of-care Urine Albumin-to-Creatinine Ratio (UACR) kidney health checks
– Using specialised simulation goggles, attendees will deeply understand the daily challenges of patients with vision impairment
– “Build your own Patient-Centred Care Pathway” station where participants can co-design a personalised ecosystem
– “Challenge Your Balance” interactive tool simulating Friedreich Ataxia symptoms
– Immersive experience of what it means to live with IBD Pick a Card – Walk in My Shoes activity, where attendees engage with lived patient scenarios
– Photo booth with social media frames and fact cards
PharmAus 2025 promises to be an evening of insight, engagement, and collaboration.